Table 4.
Complications of external cephalic version (ECV) and drug related adverse events in complete case analysis. Values are numbers (percentages) unless stated otherwise
| Complications | Atosiban (n=410) | Fenoterol (n=408) | Relative risk (95% CI) |
|---|---|---|---|
| Non-reassuring fetal heart rate after ECV attempt resulting in emergency delivery* | 0 (0.0) | 1 (0.2) | - |
| Placental abruption† | 1 (0.2) | 0 (0.0) | - |
| Emergency delivery‡ | 0 (0.0) | 2 (0.4) | - |
| Adverse events due to medication§ | 0 (0.0) | 1 (0.2) | - |
| Cessation of treatment due to side effects¶ | 0 (0.0) | 1 (0.2) | - |
| Minor side effects** | 86 (30.0) | 224 (75.7) | 0.40 (0.33 to 0.48) |
| Palpitations†† | 15 (5) | 209 (71) | 0.07 (0.04 to 0.12) |
| Dizziness‡‡ | 25 (9) | 55 (19) | 0.47 (0.30 to 0.73) |
| Flushes§§ | 17 (6) | 99 (34) | 0.18 (0.11 to 0.29) |
Minor side effects were defined as one or a combination of: palpitations, nausea, vomiting, headaches, flushing, and dizziness.
*Missing data: n=402 for atosiban and n=399 for fenoterol owing to missing data.
†Missing data: n=392 for atosiban, n=390 for fenoterol.
‡Missing data: n=391 for atosiban, n=391 for fenoterol.
§Missing data: n=399 for atosiban, n=396 for fenoterol.
¶Missing data: n=399 for atosiban, n=396 for fenoterol.
**Missing data: n=287 for atosiban, n=296 for fenoterol.
††Missing data: n=287 for atosiban, n=296 for fenoterol.
‡‡Missing data: n=285 for atosiban, n=292 for fenoterol.
§§Missing data: n=287 for atosiban, n=295 for fenoterol.